Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - INTEGRATED BIOPHARMA INC | ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - INTEGRATED BIOPHARMA INC | ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - INTEGRATED BIOPHARMA INC | ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - INTEGRATED BIOPHARMA INC | ex31-1.htm |
| EX-21 - EXHIBIT 21 - INTEGRATED BIOPHARMA INC | ex21.htm |
| 10-K - FORM 10-K - INTEGRATED BIOPHARMA INC | inbp20170630_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated September 1, 2017, with respect to the consolidated financial statements included in the Annual Report of Integrated Biopharma, Inc. on Form 10-K for the years ended June 30, 2017 and June 30, 2016. We hereby consent to the incorporation by reference of said report in the Registration Statements of Integrated BioPharma, Inc. on Forms S-8 (Nos. 333-37509, 333-87456 and 333-87458) and the Registration Statements on Forms S-3 (Nos. 333-144155 and 333-149855).
/s/ Friedman LLP
East Hanover, New Jersey
September 1, 2017